2055990-96-8
Chemical Structure
CCG 258001
- CAS No.: 2055990-96-8
- Formula:C20H22FN3O
- Molecular Weight:339.41
IUPAC Name: 5-(((3S,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methoxy)-1H-indazole
InChIKey: XIIZQRYNTNWHQN-LPHOPBHVSA-N
SMILES: C(OC=1C=C2C(=CC1)NN=C2)[C@H]3[C@@H](CCN(C)C3)C4=CC=C(F)C=C4
Biological Activity: CCG 258001 is a GRK inhibitor with IC50 values of 0.29, 51.8, and 33 µM against GRK2, GRK1, and GRK5, respectively. CCG 258001 inhibits GRK activity in cardiomyocytes and other muscle cells. CCG 258001 is applicable to the research of heart diseases, including heart failure, myocardial hypertrophy, and hypertension[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CCG 258001 | CCG 258001 is a GRK inhibitor with IC50 values of 0.29, 51.8, and 33 µM against GRK2, GRK1, and GRK5, respectively. CCG 258001 inhibits GRK activity in cardiomyocytes and other muscle cells. CCG 258001 is applicable to the research of heart diseases, including heart failure, myocardial hypertrophy, and hypertension. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
